Scarica l'app Stockscreener
0.8221
0.69%
0.0056
Dopo l'orario di chiusura:
.84
0.0179
+2.18%
Invivyd Inc Borsa (IVVD) Ultime notizie
Invivyd Inc (IVVD-Q) Stock Price and News - The Globe and Mail
BTIG Sticks to Its Buy Rating for Invivyd (IVVD) - The Globe and Mail
Invivyd,Vyd2311 Combined With Mrna Covid-1 - Moomoo
Invivyd’s Covid-directed mAb hits Phase III safety goals - Yahoo Finance
H.C. Wainwright reiterates Invivyd stock rating on trial data By Investing.com - Investing.com Nigeria
Invivyd stock reports positive LIBERTY safety data - AD HOC NEWS
Why Is Invivyd Stock Trading Lower Today?Invivyd (NASDAQ:IVVD) - Benzinga
Invivyd drops after delaying late-stage trial data for COVID therapy - TradingView
Ascletis challenges psoriasis field with pill; Invivyd plans Covid filing - Endpoints News
Invivyd Reports Positive Phase 3 LIBERTY Results for VYD2311 and Plans Accelerated Approval Submission - Yahoo Finance
Invivyd, Inc. (IVVD) Discusses LIBERTY Phase III Topline Data and Next Steps for VYD2311 Regulatory SubmissionSlideshow (NASDAQ:IVVD) 2026-09-29 - Seeking Alpha
Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety - TipRanks
Form 8K Invivyd Inc For: 29 September By Investing.com - Investing.com Nigeria
A 210-person study compared Invivyd (IVVD)'s COVID-19 antibody with a vaccine. Event rates differed. - Stock Titan
In a trial, 56.5% had an adverse event, injection reaction or allergy with Invivyd's COVID antibody, versus 91.4% with an mRNA vaccine. - Stock Titan
Invivyd Inc (IVVD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Invivyd stock falls 8 percent as earnings miss estimates - AD HOC NEWS
Invivyd, Inc.(NasdaqGM: IVVD) added to S&P Global BMI Index - marketscreener.com
3 Small-Cap Biotechs With Binary Catalysts on the Calendar - marketbeat.com
INVIVYD INC (IVVD) Stock Chart - ChartMill
IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% - Stocktwits
Invivyd to Participate in Upcoming September Investor Conferences - manilatimes.net
Invivyd management will join two live webcast chats in September - Stock Titan
Invivyd stock holds steady as investors watch recent trial progress - ad-hoc-news.de
IVVD News | INVIVYD INC (NASDAQ:IVVD) - ChartMill
Invivyd Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout - Fierce Biotech
Invivyd names chairman Marc Elia as chief executive, ahead of pivotal VYD2311 data - The Pharma Letter
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Invivyd stock falls as investors await VYD2311 data - ad-hoc-news.de
Six new hires receive rights to buy 255,000 Invivyd shares - Stock Titan
Director at Invivyd (IVVD) granted 100K stock options - Stock Titan
No Invivyd (NASDAQ: IVVD) shares listed in company director's ownership filing - Stock Titan
Invivyd appoints Marc Elia CEO amid board reshuffle - The Globe and Mail
New multi-million-share option grant for Invivyd (IVVD) CEO - stocktitan.net
Invivyd, Inc. Announces Board Appointments - marketscreener.com
New Haven COVID drugmaker names new CEO ahead of key trial results - Hartford Business Journal
Invivyd Names Chairman Marc Elia as CEO - marketscreener.com
Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY - The Manila Times
Invivyd Names Marc Elia CEO, Adds New Independent Director as VYD2311 Phase 3 Studies Near Completion - Quiver Quantitative
Invivyd (IVVD) gives its new CEO rich equity and a potential 0.5%–1.5% payout on any sale worth at least $5B, as Phase 3 COVID antibody data near. - Stock Titan
Cantor Fitzgerald reiterates Invivyd stock rating on COVID trends By Investing.com - Investing.com UK
Cantor Fitzgerald reiterates Invivyd stock rating on COVID trends - Investing.com
Invivyd (IVVD) EPS and Revenue: The Bottom-Line Figure Trails Its Comparison in Latest Trading; Share Response - careplusvn.com
IVVD|Invivyd Inc|Price:0.997|Chg%:+0.046 - TradingKey
Invivyd (IVVD) Results Check: Profit Per Share Falls Below Its Benchmark on the Day; Price Move: The Stock Ends Up 2.65%Earnings Sentiment Score - vinanet.vn
Invivyd Stock (IVVD) Opinions on Upcoming Phase 3 Results - Moomoo
Invivyd (IVVD) Q1 2026 Results: The EPS Result Is Below Expectation; Closing Reaction: Shares Finish 10.53% Higher for the Current SessionEPS Revision Trend - vinanet.vn
FY2026 EPS Estimates for Invivyd Increased by HC Wainwright - MarketBeat
Invivyd CSO Robert Allen III sells $29,295 in stock By Investing.com - Investing.com South Africa
Invivyd chief legal officer Jill Andersen sells $52,780 in shares By Investing.com - Investing.com Australia
Invivyd CCO Timothy Lee sells $31,670 in shares By Investing.com - Investing.com Nigeria
Invivyd CFO William Duke sells $31,670 in company stock By Investing.com - Investing.com South Africa
Invivyd CFO William Duke sells $31,670 in company stock - Investing.com
Invivyd CHRO Julie Green sells $31,670 in company stock - Investing.com India
Invivyd CSO Robert Allen III sells $29,295 in stock - Investing.com
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):